Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and immunogenicity of a 25-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive healthy adults: Results from 2 randomised, controlled clinical trials.
Journal: Vaccine
Published: November 18, 2025
Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 01, 2021
A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates.
Journal: Vaccine
Published: October 28, 2019
Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes disease.
Journal: Vaccine
Published: March 13, 2019
Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial.
Journal: The Journal of infectious diseases
Published: January 24, 2018
Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings From a Randomized Trial.
Journal: The Journal of infectious diseases
Published: September 08, 2016
Ensuring participant safety and trial integrity with clinical trials oversight.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: December 11, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026